Dynavax Technologies Corporation is a biopharmaceutical company focused on the prevention of infectious disease, the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. We develop immunotherapies based on cutting-edge Toll-Like Receptor (TLR) biology and its ability to modulate the immune system.